165 related articles for article (PubMed ID: 32505733)
1. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.
Su Y; Liu Z; Yang L; Li Y; Jiang S; Yao H; Du G
Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):894-904. PubMed ID: 32505733
[TBL] [Abstract][Full Text] [Related]
2. Association of peroxisome proliferator activated receptor-γ gene with non-alcoholic fatty liver disease in Asian Indians residing in north India.
Bhatt SP; Nigam P; Misra A; Guleria R; Luthra K; Pandey RM; Pasha MA
Gene; 2013 Jan; 512(1):143-7. PubMed ID: 23031808
[TBL] [Abstract][Full Text] [Related]
3. Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis.
Xie R; Tang S; Yang Y
J Diabetes Complications; 2022 Oct; 36(10):108261. PubMed ID: 36055011
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala on ethnic susceptibility to diabetes in Uygur, Kazak and Han subjects.
Li LL; Ma XL; Ran JX; Sun XF; Xu LM; Ren J; Mao XM
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):187-91. PubMed ID: 17941898
[TBL] [Abstract][Full Text] [Related]
5. Interaction Between AGTR1 and PPARγ Gene Polymorphisms on the Risk of Nonalcoholic Fatty Liver Disease.
Zhu P; Lu H; Jing Y; Zhou H; Ding Y; Wang J; Guo D; Guo Z; Dong C
Genet Test Mol Biomarkers; 2019 Mar; 23(3):166-175. PubMed ID: 30793973
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.
Lee YH; Bae SC; Song GG
Genet Test Mol Biomarkers; 2014 May; 18(5):341-8. PubMed ID: 24697566
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.
Domenici FA; Brochado MJ; Martinelli Ade L; Zucoloto S; da Cunha SF; Vannucchi H
Gene; 2013 Oct; 529(2):326-31. PubMed ID: 23891824
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients.
Gupta AC; Chaudhory AK; Sukriti ; Pande C; Sakhuja P; Singh Y; Basir SF; Sarin SK
Hepatol Int; 2010 Dec; 5(1):575-80. PubMed ID: 21442055
[TBL] [Abstract][Full Text] [Related]
9. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
10. Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: a meta-analysis.
Wang J; Guo X; Wu P; Song J; Ye C; Yu S; Zhang J; Dong W
Gene; 2013 Oct; 528(2):328-34. PubMed ID: 23891820
[TBL] [Abstract][Full Text] [Related]
11. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.
Saremi L; Lotfipanah S; Mohammadi M; Hosseinzadeh H; Fathi-Kazerooni M; Johari B; Saltanatpour Z
Cell Mol Biol Lett; 2019; 24():12. PubMed ID: 30923554
[TBL] [Abstract][Full Text] [Related]
12. Association between the PNPLA3 I148M polymorphism and non-alcoholic fatty liver disease in the Uygur and Han ethnic groups of northwestern China.
Zhang Y; Cai W; Song J; Miao L; Zhang B; Xu Q; Zhang L; Yao H
PLoS One; 2014; 9(10):e108381. PubMed ID: 25290313
[TBL] [Abstract][Full Text] [Related]
13. Ala/Ala genotype of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ2 gene is associated with obesity and insulin resistance in Asian Indians.
Bhatt SP; Misra A; Sharma M; Luthra K; Guleria R; Pandey RM; Vikram NK
Diabetes Technol Ther; 2012 Sep; 14(9):828-34. PubMed ID: 22694222
[TBL] [Abstract][Full Text] [Related]
14. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
Hui Y; Yu-Yuan L; Yu-Qiang N; Wei-Hong S; Yan-Lei D; Xiao-Bo L; Yong-Jian Z
Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
Mirzaei H; Akrami SM; Golmohammadi T; Doosti M; Heshmat R; Nakhjavani M; Amiri P
Metab Syndr Relat Disord; 2009 Oct; 7(5):453-8. PubMed ID: 19558269
[TBL] [Abstract][Full Text] [Related]
16. Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.
Li L; Cheng LX; Nsenga R; He MA; Wu TC
Clin Cardiol; 2006 Jul; 29(7):300-4. PubMed ID: 16881538
[TBL] [Abstract][Full Text] [Related]
17. Central obesity and body fat, but not body mass index, are associated with the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor γ gene in a population with a high consumption of saturated and trans-fatty acids.
Aguayo-Armendáriz J; Montalvo-Corral M; González-Martínez KA; Grijalva-Haro MI; Ballesteros-Vásquez MN; Caire-Juvera G; Moya-Camarena SY
Nutr Res; 2018 Sep; 57():28-35. PubMed ID: 30122193
[TBL] [Abstract][Full Text] [Related]
18. Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus.
Hsieh MC; Lin KD; Tien KJ; Tu ST; Hsiao JY; Chang SJ; Lin SR; Shing SJ; Chen HC
Metabolism; 2010 Aug; 59(8):1139-44. PubMed ID: 20045142
[TBL] [Abstract][Full Text] [Related]
19. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 Oct; 17(100):361-4. PubMed ID: 15690702
[TBL] [Abstract][Full Text] [Related]
20.
Ji F; Liu Y; Hao JG; Wang LP; Dai MJ; Shen GF; Yan XB
Aging (Albany NY); 2019 Sep; 11(18):7847-7858. PubMed ID: 31548436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
